Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
FBG, TBA, blood lipids, vitamin B12 and 25-hydroxyvitamin D during early pregnancy, FBG, total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) during late pregnancy were significantly higher in the obesity group than in the control group.
Source: Basic information and laboratory indicators of the pregnant women. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study protocol.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
After applying exclusion criteria: removing individuals with multiple gestation(N = 2), assisted reproductive techniques (ART, N = 6), pregestational diabetes mellitus (PGDM, N = 28), hypertension (N = 17), vaginal delivery(N = 764) or those with incomplete clinical data(N = 339), a final analytical sample of 179 participants was retained.
Source: Methods.
This study protocol was approved by the Medical Ethics Committee of The Affiliated Lihuili Hospital of Ningbo University (Approval No.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Multi-site metabolomics reveals one-carbon and placental steroid disruption in maternal pre-pregnancy obesity linked to adverse pregnancy outcomes
Study protocol · Frontiers in Medicine · 2026
Original publication title
Multi-site metabolomics reveals one-carbon and placental steroid disruption in maternal pre-pregnancy obesity linked to adverse pregnancy outcomes
© 2026 Ye, Liu, Zou, Wu and Zhang.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
This study characterized metabolomic profiles of maternal adipose tissue, placenta, and cord blood in pre-pregnancy obesity and explored links to adverse pregnancy outcomes (APOs).
Source: PurposeAbstract: What methods does the paper describe?
From a prospective cohort (Oct 2024: Oct 2025, n = 1,335), 25 obese (pre-pregnancy BMI ≥ 28 kg/m2) and 25 control women undergoing cesarean section were included. Visceral adipose, placenta, and umbilical vein plasma were analyzed using UHPLC-MS/MS. Metabolite differences were analyzed using Random Forest modeling, OPLS-DA, KEGG pathway enrichment analysis, and correlation analysis with clinical indicators, including gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy (HDP), preterm birth, macrosomia, postpartum hemorrhage (PPH), and various laboratory parameters. In an independent external cohort, mRNA expression levels of key steroidogenic enzymes in placental tissues were verified by qRT-PCR.
Source: MethodsAbstract: Results
The obesity group showed significantly higher incidences of GDM, HDP, PPH and higher neonatal weight. Vitamin B12 and folic acid were key discriminators across all compartments. Adipose tissue metabolites were enriched in arginine/proline, pentose phosphate, and cysteine/methionine metabolism. Placenta was enriched in steroid hormone biosynthesis pathways. Cord blood additionally showed enrichment in TCA cycle, glutamatergic and serotonergic synapses. Key compartment-specific metabolites included etiocholanolone (adipose), 16-glucuronide-estriol (placenta), and 5α-androstan-3-one (cord blood), all of which correlated with clinical indicators. The mRNA expression changes of key steroidogenic enzymes in placental tissues paralleled the alterations in their corresponding metabolite abundances.
Source: ResultsAbstract: Conclusion
Pre-pregnancy obesity-related adverse pregnancy outcomes are driven by a disrupted maternal-fetal metabolic axis characterized by three core features: global dysfunction of one-carbon metabolism exemplified by vitamin B12 and folic acid abnormalities, placental steroid hormone biosynthesis abnormalities as the central hub, and disturbances in fetal energy and neurotransmitter metabolism as the downstream consequence. Monitoring these metabolites may enable early risk identification and guide targeted interventions for placental steroid metabolism.
Source: ConclusionAuthors’ abstract
Purpose
This study characterized metabolomic profiles of maternal adipose tissue, placenta, and cord blood in pre-pregnancy obesity and explored links to adverse pregnancy outcomes (APOs).
Methods
From a prospective cohort (Oct 2024: Oct 2025, n = 1,335), 25 obese (pre-pregnancy BMI ≥ 28 kg/m2) and 25 control women undergoing cesarean section were included. Visceral adipose, placenta, and umbilical vein plasma were analyzed using UHPLC-MS/MS. Metabolite differences were analyzed using Random Forest modeling, OPLS-DA, KEGG pathway enrichment analysis, and correlation analysis with clinical indicators, including gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy (HDP), preterm birth, macrosomia, postpartum hemorrhage (PPH), and various laboratory parameters. In an independent external cohort, mRNA expression levels of key steroidogenic enzymes in placental tissues were verified by qRT-PCR.
Results
The obesity group showed significantly higher incidences of GDM, HDP, PPH and higher neonatal weight. Vitamin B12 and folic acid were key discriminators across all compartments. Adipose tissue metabolites were enriched in arginine/proline, pentose phosphate, and cysteine/methionine metabolism. Placenta was enriched in steroid hormone biosynthesis pathways. Cord blood additionally showed enrichment in TCA cycle, glutamatergic and serotonergic synapses. Key compartment-specific metabolites included etiocholanolone (adipose), 16-glucuronide-estriol (placenta), and 5α-androstan-3-one (cord blood), all of which correlated with clinical indicators. The mRNA expression changes of key steroidogenic enzymes in placental tissues paralleled the alterations in their corresponding metabolite abundances.
Conclusion
Pre-pregnancy obesity-related adverse pregnancy outcomes are driven by a disrupted maternal-fetal metabolic axis characterized by three core features: global dysfunction of one-carbon metabolism exemplified by vitamin B12 and folic acid abnormalities, placental steroid hormone biosynthesis abnormalities as the central hub, and disturbances in fetal energy and neurotransmitter metabolism as the downstream consequence. Monitoring these metabolites may enable early risk identification and guide targeted interventions for placental steroid metabolism.
Publication and source details
Original title: Multi-site metabolomics reveals one-carbon and placental steroid disruption in maternal pre-pregnancy obesity linked to adverse pregnancy outcomes
Ke Ye; Yan Liu; Jinghui Zou; Hangyu Wu; Yisheng Zhang
Frontiers in Medicine · 2026
* Correspondence: Yisheng Zhang zhangysnbu@163.comThese authors have contributed equally to this work and share first authorship
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:21:29.633348+00:00
DOI: 10.3389/fmed.2026.1904730 · PMC13669156